Welcome to LookChem.com Sign In|Join Free

CAS

  • or

60207-90-1

Post Buying Request

60207-90-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60207-90-1 Usage

Overview

The triazole compound propiconazole (Pcz), 1-[[2-(2,4- dichlorophenyl)-4-propyl-1, 3-dioxolan-2-yl]methyl]-1,2,4-triazole, is a kind of triazole fungicide (Fig. 1). It is used extensively in a variety of applications. It is used on grasses grown for seed, mushrooms, corn, wild rice, peanuts, almonds, sorghum, oats, pecans, apricots, peaches, nectarines, plums and prunes. On cereals it controls diseases caused by Erysiphe graminis, Leptosphaeria nodorum, Pseudocerosporella herpotrichoides, Puccinia spp., Pyrenophora teres, Rhynchosporium secalis, and Septoria spp.[1, 2, 3] . Wheat crops are among the commodities most heavily treated with fungicides in the United States, and propiconazole comprises approximately 90% of this application[4]. Propiconazole is soluble in water at a concentration of 110 mg/L, and concentrations as high as 24 mg/L have been reported in waters receiving runoff from agricultural endeavors using the fungicide[5]. It can act as a potent inhibitor of BR biosynthesis as has been found that it has inhibitory effect on hypocotyl elongation of cress plants (Lepidium sativum)[6]. This inhibitory effect of Pcz was reversed by co-application with brassinolide. Based on the Pcz structure additional BR inhibitors, such as 2RS, 4RS-1-[2-(4- trifluoromethylphenyl)-4-n-propyl-1, 3-dioxolan-2-ylmethyl]-1H- 1,2,4-triazole, were identified[6]. On the other hand, Pcz has been commercially used as fungistat (BannerMaxx, Syngenta) against a broad range of phytopathogenic fungi. Its fungistatic mode of action is the same as that of Ucz and Pac, blocking of lanosterol 14R-demethylase (CYP51A1)[7, 8]. Pcz has also been studied extensively for its toxicity on plants, animals, humans, and the environment[9, 10]. Here we present a molecular genetic analysis of Pcz’s effects on Arabidopsis and maize seedlings. Figure 1 the chemical structure of propiconazole

Application

Triazole fungicides are used as clinical drugs and agricultural pesticides useful for the treatment and protection of corns, fruits, and other plants[11-13]. It is a systemic fungicide with a broad range of activity and a wide range of agricultural cropping applications. It can be used for controlling the fungi diseases caused by Erysiphe graminis; Leptosphaeria nodorum; Pseudocerosporella herpotrichoides; Puccinia spp.; Pyrenophora teres; Rhynchosporium secalis; Septoria spp. It can be used at various plants such as Mushrooms; Corn; Wild rice; Peanuts; Amonds; Sorghum; Oats; Pecan; Fruit including apricots, plums, prunes, peaches & nectarines[14].

Administration method

For the treatment of Powdery midew of grape, Anthracnose of grape, Anthrax, White rot, spray 25% EC 4000-6000 times mixed with water; For the treatment of Altermaria leaf spot and Venturia inaequalis of apple and pear, spray 25% EC 5000-6000 times mixed with water. For the treatment of Leaf spot and necrosis of peanuts, spray 25% EC 2500-4000 times mixed with water. For the treatment of leaf spot of bananas, spray 25% EC 1500 times mixed with water. For the treatment of Anthrax of Watermelon, Powdery mildew of water-melon, and Leaf spot of watermelon, spray 25% EC 4000-6000 times mixed with water. For the treatment of leaf spot of corn, spray 25% EC 1500 times mixed with water. For the treatment of powdery mildew of wheat, ornamental rust of wheat, spray 25% EC 4000-6000 times mixed with water. For the treatment of Bakanae disease of rice, dip in the seed mixed with water 1000 times for 2 to 3 days[15].

Mode of action

Propiconazole's mode of action is demethylation of C-14 during ergosterol biosynthesis (through inhibiting the activity of 14a-demethylase as detailed below), and leading to accumulation of C-14 methyl sterols. The biosynthesis of these ergosterols is critical to the formation of cell walls of fungi. This lack of normal sterol production slows or stops the growth of the fungus, effectively preventing further infection and/or invasion of host tissues. Therefore, propiconazole is considered to be fungistatic or growth inhibiting rather than fungicidal or killing [2]. Sterol 14a-demethylase is a key enzyme for the fungal ergosterol biosynthesis. Inhibition of Sterol 14a-demethylase causes not only depletion of ergosterol but also accumulation of 14-methylsterols in fungal cells [16]. Since 14-methylsterols are unfavourable sterols for bio-membranes, inhibition of 14a-demethylase) seriously impairs the membrane function by the synergistic effects of ergosterol depletion and 14-methylsterol accumulation. Hence, Sterol 14a-demethylase inhibitors are an important class of antifungal agents, and a number of azole derivatives have been put to practical use as the potent antifungal medicines and agrochemicals of this class. Propiconazole is also a potent inhibitor of Brassinosteroids biosynthesis. Brassinosteroids (BRs) are poly-hydroxylated steroidal hormones with profound effects on several physiological plant responses. They are involved in regulating cell elongation and division, vascular differentiation, photomorphogenesis, leaf angle inclination, seed germination, stomata development, as well as suppression of leaf senescence and abscission [17-22]. Studies showed that several steps of BR biosynthesis are mediated by cytochrome P450 monooxygenases (P450s) [23]. Triazole compounds have been shown to inhibit P450s, one of the largest and most ubiquitous groups of plant enzymes that catalyze oxidative processes in life systems [24].

Toxicity and environmental issue

Propiconazole (PCZ) is among the most heavily used in agriculture [25]. Triazole fungicides have a shorter half-life and lower bioaccumulation than organochlorine pesticides, but detrimental effects on the aquatic ecosystem may arise from spray drift or surface run-off after rainfall [11]. They have been reported to undergo transformation to secondary metabolites in terrestrial mammals [12, 26]. Acute toxicity The acute toxicity to mammals for propiconazole technical are an acute oral LD50 for rats of 1,517 mg/kg and 1,344 mg/kg for rabbits. The acute dermal LD50 for rabbit was reported to be >4,000 mg/kg. Propiconazole was considered a slight irritant in rabbit skin and eye irritation studies. A skin sensitization study in guinea pigs demonstrated no allergic effect (2). The acute toxicity to mammals for the formulated products Orbit 3.6E, Tilt 3.6E and Banner 1.1E was as follows: acute oral LD50 for rats of 1,310 mg/kg. The acute dermal LD50 for rabbit was reported to be >5,010 mg/kg. The formulated products were considered a moderate irritant in rabbit skin and eye irritation studies. A skin sensitization study in guinea pigs resulted in the formulated product being considered a sensitizer [2, 27]. EPA toxicologists have recommended that the developmental No-ObservedEffect-Level (NOEL) of 30 mg/kg/day from the rat developmental toxicity study be used for acute dietary risk calculations. The lowest-effect-level (LEL) of 90 mg/kg/day is based on the increased incidence of unossified sternebrae, rudimentary ribs, and shortened or absent renal papillae. Chronic effect In two-year feeding studies in mice, the NOEL was established at 100 ppm. Significant increases were noted in the incidence of spontaneous liver tumors (benign) observed in male mice at the highest feeding level only. In two-year rat feeding studies, the no-effect-level was established at 100 ppm. There were no tumors in the rat at any feeding level. In one-year feeding studies in dogs, the NOEL was established at 250 ppm, the highest level tested (2). Based on the available chronic toxicity data, EPA has established the RfD for propiconazole at 0.013 mg/kg/day. This RfD is based on a 1 year dog feeding study with a NOEL of 1.25 mg/kg/day and an uncertainty factor of 100. The uncertainty factor of 100 was applied to account for inter-species extrapolation and intra-species variability. Mild irritation of the gastric mucosa was the effect observed at the LEL of 6.2 mg/kg/day [28]. A 21-day subchronic dermal toxicity test in rabbits found after 3 weeks (15 applications) moderate skin irritation to be the only effect following applications of propiconazole at 1000 mg/kg/day [2]. To fish Fish exposed to fungicides in the environment exhibit a variety of biochemical changes, including those in the antioxidant defense system and other biochemical indices [25]. Long-term exposure to PCZ results in significantly increased ROS in fish brain, indicating severe oxidative stress. PCZ induced ROS formation can oxidize most cellular constituents, such as DNA, proteins, and lipids, causing damage to molecules, resulting in reduced enzymatic activity and affecting cellular integrity. Moreover, PCZ can cause inhibition of Na+–K+ATPase in fish brain after long-term exposure probably disturbed the Na+–K+ pump, resulting in the limitation of Na+–K+-ATPase synthesizing capability.

References

Worthing, C. R., ed. 1983. The pesticide manual: A world compendium. Croydon, England: The British Crop Protection Council. Technical Information Bulletin for Propiconazole Fungicide. Ciba-Geigy. Greensboro, NC. 15 pp. W. T. Thomson. 1997. Agricultural Chemicals. Book IV: Fungicides. 12th edition. Thomson Publications, Fresno, CA. Garry VF, Schreinemachers D, Harkins ME, Griffith J. 1996. Pesticide appliers, biocides, and birth defects in rural Minnesota. Environ Health Perspect 104:394–399. Mortensen SR, Johnson KA, Weisskop CP, Hooper MJ, Lacher TE, Kendall RJ. 1998. Avian exposure to pesticides in Costa Rican Banana plantations. Bull Environ Contam Toxicol 60:562–568. Sekimata K, Han SY, Yoneyama K, Takeuchi Y, Yoshida S, et al. (2002) A specific and potent inhibitor of brassinosteroid biosynthesis possessing a dioxolane ring. J Agric Food Chem 50: 3486 3490. Yoshida Y, Aoyama Y (1991) Sterol I4a-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14a-demethylase (P-45014DM) of yeast. Biochem Soc Trans 19: 778–782. Wiggins TE, Baldwin BC (1984) Binding of azole fungicides related to dichlobutrazol to cytochrome P450. Pest Sci 14: 206–209. Li Z, Zlabek V, Velisek J, Grabic R, Machova J, et al. (2011) Multiple biomarkers responses in juvenile rainbow trout, Oncorhynchus mykiss, after acute exposure to a fungicide propiconazole. Environ Toxicol DOI: 10.1002/ tox.20701. Thorstenson CW, Lode O (2001) Laboratory degradation studies of bentazone, dichlorprop, MCPA, and propiconazole in Norwegian soils. J Environ Qual 30: 947–953. Konwick BJ, Garrison AW, Avants JK, Fisk AT. 2006. Bioaccumulation and biotransformation of chiral triazole fungicides in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicol 80:372–381. Chen PJ, Moore T, Nesnow S. 2008. Cytotoxic effects of propiconazole and its metabolites in mouse and human hepatoma cells and primary mouse hepatocytes. Toxicol Vitro 22:1476–1483. Li ZH, Randak T. 2009. Residual pharmaceutically active compounds (PhACs) in aquatic environment—Status, toxicity and kinetics: A review. Vet Med 52:295–314. https://sitem.herts.ac.uk/aeru/ppdb/en/Reports/551.htm http://www.udpf.com/pz2b7acb4-cz69c79f-propiconazole-25-ec.html Van den Bossche, H. (1985) in Current Topics in Medical Mycology (McCinnis, M. K. ed.), vol.1, pp. 3 13-345, Springer-Verlag, New York Azpiroz R, Wu Y, LoCascio JC, Feldmann KA (1998) An Arabidopsis brassinosteriod-dependent mutant is blocked in cell elongation. Plant Cell 10: 219–230. Yamamoto R, Demura T, Fukuda H (1997) Brassinosteroids induce entry into the final stage of tracheary element differentiation in cultured Zinnia cells. Plant Cell Physiol 38: 980–983. Neff MM, Nguyen SM, Malancharuvil EJ, Fujioka S, Noguchi T, et al. (1999) BAS1: a gene regulating brassinosteroid levels and light responsiveness in Arabidopsis. Proc Natl Acad Sci U S A 96: 15316–15323. Wada K, Marumo S, Ikekawa N, Morisaki M, Mori K (1981) Brassinolide and homobrassinolide promotion of lamina inclination of rice seedlings. Plant Cell Physiol 22: 323–325. Sasse JM, Smith R, Hudson I (1995) Effect of 24-epibrassinolide on germination of seeds of Eucalyptus camaldulensis in saline conditions. Proc Plant Growth Regul Soc Am 22: 136–141. Kim TW, Michniewicz MM, Bergmann DC, Wang ZY (2012) Brassinosteroid inhibits stomatal development by releasing GSK3-mediated inhibition of a MAP kinase pathway. Nature, Epub 2012/02/ 07. Fujioka S, Yokota T (2003) Biosynthesis and metabolism of brassinosteroids. Annu Rev Plant Biol 54: 137–164. Mizutani M, Ohta D (2010) Diversification of P450 genes during land plant evolution. Annu Rev Plant Biol 61: 291–315. Egaas, E., Sandvik, M., Fjeld, E., Kallqvist, T., Goksoyr, A., Svensen, A., 1999. Some effects of the fungicide propiconazole on cytochrome P450 and glutathione Stransferase in brown trout (Salmo trutta). Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 122, 337–344. Sun, G.B., Thai, S.F., Tully, D.B., Lambert, G.R., Goetz, A.K., Wolf, D.C., Dix, D.J., Nesnow, S., 2005. Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liver. Toxicol. Lett. 155, 277–287. Technical Paper. Banner: A Turf Fungicide. Ciba-Geigy. Greensboro, NC. 21 pp. U.S. Environmental Protection Agency. Propiconazole; Pesticide Tolerances for Emergency Exemptions. Federal Register Document 96-29020. November 12, 1996.

Description

Propiconazole is a mixture of four stereoisomers and was first developed in 1979 by Janssen Pharmaceutical of Belgium.

Chemical Properties

Different sources of media describe the Chemical Properties of 60207-90-1 differently. You can refer to the following data:
1. normally provided as a yellow liquid
2. Colorless solid or a yellow thick liquid. Odorless. Commercial product is available as an emulsifi- able concentrate. Physical and toxicological properties may be affected by carrier solvents in commercial formulations.

Uses

Different sources of media describe the Uses of 60207-90-1 differently. You can refer to the following data:
1. Labelled Propiconazole (P770100). Systemic foliar fungicide. Agricultural fungicide.
2. Agricultural fungicide.
3. Propiconazole is a triazole-based fungicide that is used to control fungi in agriculture, on turf, and in wood.

General Description

Yellowish odorless liquid. Non corrosive. Used as a fungicide.

Reactivity Profile

A triazole derivative.

Flammability and Explosibility

Notclassified

Agricultural Uses

Fungicide: Used to control fungi on a broad range of crops and turf. Used on ornamentals, range land and rights-of-way to prevent and control powdery mildew and fungi on hardwoods and conifers.

Trade name

ALAMO?; BANNER?; BENIT?; BREAK?; BUMPER?; CGA-64250?; CGA-92710 F?; DESMEL?; FIDIS?; JUNO?; MANTI? S; MAXX?; NOVEL?; ORBIT?; PRACTIS?; PROPIMAX?; RADAR?; RESTORE?; SPIRE?; STRATEGO? (trifloxystrobin + propiconazole); TASPA?; TILT?; WOCOSIN?

Potential Exposure

Propiconazole is a triazole fungicide used to control fungi on a broad range of crops and turf. Used on ornamentals, range land and rights-of-way to pre- vent and control powdery mildew and fungi on hardwoods and conifers.

Environmental Fate

Routes and Pathways, and Relevant Physicochemical Properties Log Kow=3.72 Solubilities: 47 g l1 in n-hexane; completely miscible with ethanol, acetone, toluene, and octanol; soluble in most organic solvents; in water = 100 mg l-1 at 25°C Henry's law constant= 4.1×10-9 atm-cu mmol-1 at 25°C Partition Behavior in Water, Sediment, and Soil Terrestrial Fate Propiconazole penetrates the terrestrial environment in its function as a fungicide for a variety of crops. In the terrestrial environment, propiconazole is presented to be slightly persistent to persistent. Biotransformation is an important route of transformation for propiconazole, with major transformation products being 1,2,4-triazole and compounds hydroxylated at the dioxolane moiety. Phototransformation on soil or in air is not important for propiconazole transformation. Propiconazole appears to have medium to low mobility in soil. It has the potential to reach ground water through leaching, especially in soils with low organic matter content. Propiconazole is typically detected in the upper soil layers, but transformation products were detected deeper in the soil profile. Environmental Persistency Propiconazole is persistent and relatively immobile in most soil and aqueous environments. Propiconazole degradation in the aquatic environment appears to be dependent solely on aqueous photolysis. In the soil, propiconazole dissipation appears to be dependent on binding to soil organic matter content. The average half-life in soils ranges from months to a year. Propiconazole is expected to biodegrade in the environment. The estimated half-life of propiconazole in aerobic soils is about 40–70 days, and in aerobic waters is about 25–85 days. Based on monitoring data and field tests, propiconazole has an estimated half-life of about 60–96 days in typical soils. No hydrolysis of propiconazole at environmentally relevant pH has been observed. Propiconazole degrades into triazole compounds, which may still be toxic. Decomposition of propiconazole by heating may release toxic gases.

Metabolic pathway

The numerous metabolites of propiconazole are identified from rat urine and feces. Major sites for enzymatic attack are the propyl side chain and the cleavage of the dioxane ring. The 2,4-dichlorophenyl ring is attacked in various ways including the formation of a cyclohexadiene ring system, hydroxylation, replacement of the chlorine substituent by a hydroxy group, and introduction of a methylthio group. The 1,2,4-triazole ring is oxidatively attacked, leading to hydroxy derivatives. The vast majority of the alcoholic and phenolic metabolites are excreted as sulfuric acid and glucuronic acid conjugates. The major metabolic pathway in mice is via cleavage of the dioxane ring. Photolysis causes cleavage of the C1-triazole bond of propiconazole, liberating 1,2,4-triazole as the major product. Six more degradation products are identified which are not included in the mammalian metabolites.

Degradation

Photolysis of propiconazole (1) in hexane and methanolic solutions irradiated with a high-pressure mercury lamp gave a mixture of products 2-8 (Scheme 1) (Dureja et al., 1987). The major product isolated was 1,2,4- triazole (7). A monodechlorinated product (5) was formed in hexane. The dioxolane ring was cleaved in methanol under these conditions. Sunlight irradiation on a sandy loam soil surface for 48 days degraded 80% of the applied material and a DTs0 of about 12 days on soil was derived through further rate studies. 1,2,4-Triazole (7) was the major product identified after exposing a thin layer of propiconazole, coated as a thin film, inside a Pyrex flask to sunlight for one month.

Toxicity evaluation

Propiconazole mode of action is demethylation of C-14 during ergosterol biosynthesis and leading to accumulation of C-14 methyl sterols. The biosynthesis of these ergosterols is critical to the formation of cell walls of fungi. This lack of normal sterol production slows or stops the growth of the fungus, effectively preventing further infection and/or invasion of host tissues. Therefore, propiconazole is considered to be fungistatic or growth inhibiting rather than fungicidal or killing.

Incompatibilities

The triazoles are sensitive to heat, friction, and impact. Sensitivity varies with the type substitution to the triazole ring. Metal chelated and halogen substitution of the triazol ring make for a particularly heat sensitive material. Azido and nitro derivatives have been employed as high explosives. No matter the derivative these materials should be treated as explosives

Waste Disposal

Consult with environmental regulatory agencies for guidance on acceptable disposal practices. Contact a licensed disposal facility about surplus and nonrecyclable solutions. Burn in a chemical incinerator equipped with an afterburner and scrubber. Extra care must be exercised as the material in an organic solvent is highly flammable. In accordance with 40CFR165, follow recom- mendations for the disposal of pesticides and pesticide con- tainers. Containers must be disposed of properly by following package label directions or by contacting your local or federal environmental control agency, or by con- tacting your regional EPA office. Incineration or permanga- nate oxidation.

Check Digit Verification of cas no

The CAS Registry Mumber 60207-90-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,2,0 and 7 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 60207-90:
(7*6)+(6*0)+(5*2)+(4*0)+(3*7)+(2*9)+(1*0)=91
91 % 10 = 1
So 60207-90-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H17Cl2N3O2/c1-2-3-12-7-21-15(22-12,8-20-10-18-9-19-20)13-5-4-11(16)6-14(13)17/h4-6,9-10,12H,2-3,7-8H2,1H3

60207-90-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma-Aldrich

  • (45642)  Propiconazole  PESTANAL®, analytical standard

  • 60207-90-1

  • 45642-250MG

  • 733.59CNY

  • Detail

60207-90-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name propiconazole

1.2 Other means of identification

Product number -
Other names Propiconazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:60207-90-1 SDS

60207-90-1Synthetic route

1,2,4-Triazole
288-88-0

1,2,4-Triazole

propiconazole iodide

propiconazole iodide

Propiconazole
60207-90-1

Propiconazole

Conditions
ConditionsYield
Stage #1: 1,2,4-Triazole With sodium hydroxide In toluene Reflux;
Stage #2: propiconazole iodide In N,N-dimethyl-formamide at 90 - 100℃; Solvent;
97.5%
C15H19Cl2N4O2(1+)*Br(1-)

C15H19Cl2N4O2(1+)*Br(1-)

Propiconazole
60207-90-1

Propiconazole

Conditions
ConditionsYield
Stage #1: C15H19Cl2N4O2(1+)*Br(1-) With hydrogenchloride; sodium nitrite In water at 10 - 20℃; for 2h;
Stage #2: With water at 40℃; Temperature; Alkaline conditions;
94.3%
1,2,4-Triazole
288-88-0

1,2,4-Triazole

2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane

2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane

Propiconazole
60207-90-1

Propiconazole

Conditions
ConditionsYield
With ethyltriphenylphosphonium bromide; potassium carbonate In 1-methyl-pyrrolidin-2-one at 130℃; Reagent/catalyst;88.6%
2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane

2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane

Propiconazole
60207-90-1

Propiconazole

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: butan-1-ol / 8 h / 90 °C
2.1: hydrogenchloride; sodium nitrite / water / 2 h / 10 - 20 °C
2.2: 40 °C / Alkaline conditions
View Scheme
1-(2,4-dichlorophenyl)ethan-1-one
2234-16-4

1-(2,4-dichlorophenyl)ethan-1-one

Propiconazole
60207-90-1

Propiconazole

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dihydrogen peroxide; sodium percarbonate; bromine / 1,2-dichloro-ethane / 20 - 45 °C
2: toluene-4-sulfonic acid / toluene / 4 h / Reflux
3: potassium carbonate / dimethyl sulfoxide / 8 h / Reflux
View Scheme
potassium 1,2,4-triazolate

potassium 1,2,4-triazolate

2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane

2-(bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane

Propiconazole
60207-90-1

Propiconazole

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide for 8h; Reflux;
citric acid
77-92-9

citric acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium dihydrogen citrate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium dihydrogen citrate

Conditions
ConditionsYield
In methanol at 20℃;99%
methanesulfonic acid
75-75-2

methanesulfonic acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium methanesulfonate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium methanesulfonate

Conditions
ConditionsYield
In methanol at 20℃;99%
benzenesulfonic acid
98-11-3

benzenesulfonic acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium benzenesulfonate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium benzenesulfonate

Conditions
ConditionsYield
In methanol at 20℃;99%
maleic acid
110-16-7

maleic acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium maleate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium maleate

Conditions
ConditionsYield
In methanol at 20℃;98%
In hexane for 1h; Product distribution / selectivity;
dodecylbenzene-sulphonic acid
47221-31-8

dodecylbenzene-sulphonic acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium dodecylbenzenesulfonate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium dodecylbenzenesulfonate

Conditions
ConditionsYield
In methanol at 20℃;98%
LACTIC ACID
849585-22-4

LACTIC ACID

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium D,L-lactate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium D,L-lactate

Conditions
ConditionsYield
In methanol at 20℃;97%
toluene-4-sulfonic acid
104-15-4

toluene-4-sulfonic acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium 4-methylbenzenesulfonate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium 4-methylbenzenesulfonate

Conditions
ConditionsYield
In methanol at 20℃;96%
2-methoxyacetic acid
625-45-6

2-methoxyacetic acid

Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium methoxyacetate

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium methoxyacetate

Conditions
ConditionsYield
In methanol at 20℃;92%
Propiconazole
60207-90-1

Propiconazole

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium chloride

1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazol-4-ium chloride

Conditions
ConditionsYield
With hydrogenchloride In water; toluene for 0.333333h;90%
zinc(II) chloride
7646-85-7

zinc(II) chloride

Propiconazole
60207-90-1

Propiconazole

ZnCl2(propiconazole)2

ZnCl2(propiconazole)2

Conditions
ConditionsYield
In ethanol for 120h;76.4%
Propiconazole
60207-90-1

Propiconazole

2-[2-(2,4-dichlorophenyl)-4-propyl-[1,3]dioxolan-2-ylmethyl]-2,4-dihydro[1,2,4]triazole-3-thione
1258956-62-5

2-[2-(2,4-dichlorophenyl)-4-propyl-[1,3]dioxolan-2-ylmethyl]-2,4-dihydro[1,2,4]triazole-3-thione

Conditions
ConditionsYield
Stage #1: Propiconazole With isopropylmagnesium chloride In tetrahydrofuran at 40℃; for 1.5h;
Stage #2: With sulfur In tetrahydrofuran at 0℃; for 1h;
Stage #3: With hydrogenchloride; water In tetrahydrofuran
35%
Propiconazole
60207-90-1

Propiconazole

A

1-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone
58905-16-1

1-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone

B

C15H16ClN3O2

C15H16ClN3O2

C

4-chloro-2-(2-methyl-2H-[1,2,4]triazol-3-yl)-benzoic acid 5-hydroxy-pentyl ester

4-chloro-2-(2-methyl-2H-[1,2,4]triazol-3-yl)-benzoic acid 5-hydroxy-pentyl ester

Conditions
ConditionsYield
With water Quantum yield; Kinetics; Product distribution; Further Variations:; var. irradiation times; phototransformation; UV-irradiation;
sodium hexachloroplatinate(IV) hexahydrate

sodium hexachloroplatinate(IV) hexahydrate

Propiconazole
60207-90-1

Propiconazole

trans-[PtCl4(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)2]

trans-[PtCl4(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)2]

Conditions
ConditionsYield
In water; acetone mixing in ratio Na2PtCl6:(C2H2N3CH2(C6H3Cl2)C3H3O2C3H7)=1:1 or 1:2 in neutral water-acetone soln. for 3 h; filtration, washing with H2O; drying at room temp., elem. anal.;
hydrogenchloride
7647-01-0

hydrogenchloride

tetrachloroaurate(III)(1-)

tetrachloroaurate(III)(1-)

Propiconazole
60207-90-1

Propiconazole

HAuCl4*(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)

HAuCl4*(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)

Conditions
ConditionsYield
In water; toluene Kinetics; mixing of gold(III) soln. in hydrochloric acid with soln. of 1-(2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-trazole in toluene at 25°C; saturation of org. phase, pptn. with hexane, washing with hexane; drying, elem. anal.;
hydrogenchloride
7647-01-0

hydrogenchloride

potassium hexachloroiridate(IV)

potassium hexachloroiridate(IV)

Propiconazole
60207-90-1

Propiconazole

[1-(2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl-methyl)-1H-1,2,4-triazole(+1H)]2[IrCl6]

[1-(2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl-methyl)-1H-1,2,4-triazole(+1H)]2[IrCl6]

Conditions
ConditionsYield
In water; toluene saturating soln. of C3H7C3H3O2(CH2C2H2N3)C6H3Cl2 in toluene with 3.0 M HCl of K2IrCl6; pptn. by hexane;
hydrogenchloride
7647-01-0

hydrogenchloride

dihydrogen hexachloroplatinate(IV) hexahydrate

dihydrogen hexachloroplatinate(IV) hexahydrate

Propiconazole
60207-90-1

Propiconazole

H2PtCl6*2(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)

H2PtCl6*2(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)

Conditions
ConditionsYield
In water; toluene dissolving of H2PtCl6*6H2O in hydrochloric acid; mixing with soln. of 1-(2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-trazole in toluene; saturation of org. phase, pptn. with hexane, washing with hexane; drying, elem. anal.;
hydrogenchloride
7647-01-0

hydrogenchloride

sodium tetrachloropalladate(II)

sodium tetrachloropalladate(II)

Propiconazole
60207-90-1

Propiconazole

H2PdCl4*2(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)

H2PdCl4*2(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)

Conditions
ConditionsYield
In water; toluene Kinetics; dissolving of PdCl2 in hydrochloric acid; mixing with soln. of 1-(2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-trazole in toluene at 25°C; saturation of org. phase, pptn. with hexane, washing with hexane; drying, elem. anal.;
sodium tetrachloropalladate(II)

sodium tetrachloropalladate(II)

Propiconazole
60207-90-1

Propiconazole

trans-[PdCl2(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)2]

trans-[PdCl2(1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole)2]

Conditions
ConditionsYield
In water; acetone mixing in ratio Na2PdCl4:(C2H2N3CH2(C6H3Cl2)C3H3O2C3H7)=1:1 or 1:2 in neutral water-acetone soln. for 30 min; filtration, washing with H2O, drying at room temp., elem. anal.;
ruthenium(III) chloride hydrate
20759-14-2

ruthenium(III) chloride hydrate

Propiconazole
60207-90-1

Propiconazole

[propicanazole(+1H)][RuCl4(H2O)2]
1039726-56-1

[propicanazole(+1H)][RuCl4(H2O)2]

Conditions
ConditionsYield
In toluene soln. of Ru salt in aq. HCl stirred with soln. of ligand in 15 vol % decanol in toluene at room temp.; not isolated; monitored by NMR and IR spectroscopy;
urea
57-13-6

urea

Propiconazole
60207-90-1

Propiconazole

propiconazole - urea co-crystal

propiconazole - urea co-crystal

Conditions
ConditionsYield
In 2-Methylpentane; acetone at 20 - 50℃; for 5h;
nicotinamide
98-92-0

nicotinamide

Propiconazole
60207-90-1

Propiconazole

propiconazole - nicotinamide co-crystal

propiconazole - nicotinamide co-crystal

Conditions
ConditionsYield
In ethyl acetate; acetone at 20 - 50℃; for 5h;
tetrahydroxy-1,4-quinone
319-89-1

tetrahydroxy-1,4-quinone

Propiconazole
60207-90-1

Propiconazole

propiconazole - 2,3,5,6-tetrahydroxy-1,4-benzoquinone co-crystal

propiconazole - 2,3,5,6-tetrahydroxy-1,4-benzoquinone co-crystal

Conditions
ConditionsYield
In methanol; acetone at 50℃; for 2h;
5-Hydroxy-2-methylpyridine
1121-78-4

5-Hydroxy-2-methylpyridine

Propiconazole
60207-90-1

Propiconazole

propiconazole - 5-hydroxy-2-methylpyridine co-crystal

propiconazole - 5-hydroxy-2-methylpyridine co-crystal

Conditions
ConditionsYield
In methanol; xylene at 20 - 50℃; for 5h;
6-hydroxy-2-methylpyridine
3279-76-3

6-hydroxy-2-methylpyridine

Propiconazole
60207-90-1

Propiconazole

propiconazole - 2-hydroxy-6-methylpyridine co-crystal

propiconazole - 2-hydroxy-6-methylpyridine co-crystal

Conditions
ConditionsYield
In ethanol; acetonitrile at 50℃; for 2h;
isonicotinamide
1453-82-3

isonicotinamide

Propiconazole
60207-90-1

Propiconazole

propiconazole-isonicotinamide co-crystal

propiconazole-isonicotinamide co-crystal

Conditions
ConditionsYield
In methanol; 2-Methylpentane at 20 - 50℃; for 5h;
1,9-Nonanediol
3937-56-2

1,9-Nonanediol

Propiconazole
60207-90-1

Propiconazole

propiconazole - 1,9-nonanediol co-crystal

propiconazole - 1,9-nonanediol co-crystal

Conditions
ConditionsYield
In ethanol; 2-Methylpentane at 50℃; for 2h;

60207-90-1Relevant articles and documents

Preparation method of propiconazole

-

Paragraph 0069; 0086-0099, (2021/11/27)

The invention relates to a preparation method of propiconazole. The invention aims to solve the obvious defects that in the prior art, high-risk bromination reaction can generate a large amount of bromine-containing byproducts, unit consumption and cost are high, condensation reaction temperature is high, condensation reaction time is long, solvent recovery is difficult, and wastewater is difficult to treat. The preparation method comprises the step of carrying out condensation reaction on an intermediate 3 and triazole or triazole salt to generate propiconazole, wherein the structural formula of the intermediate 3 is shown as the specification. According to the preparation method of propiconazole, provided by the invention, high-risk bromination reaction in a traditional synthesis method is avoided, generation of bromine-containing by-products is avoided, and environmental pollution is reduced; the preparation method of propiconazole has the advantages of excellent raw material conversion rate and yield, and high product purity. Furthermore, a low-toxicity and low-cost reaction solvent can be used for replacing a high-toxicity DMSO and N, N-dimethylformamide solvent in the traditional process, the reaction is milder, the post-treatment is simplified, the operation is more convenient, the energy consumption is obviously reduced, and the method is more suitable for industrial production.

Triazole compound containing dioxolame and preparation method of intermediate of triazole compound

-

, (2021/09/04)

The invention relates to a preparation method of a dioxolane-containing triazole compound and an intermediate thereof, and the method comprises the following steps: reacting a compound shown as a formula (V) with a compound shown as a formula (IV) in the presence of Lewis acid to prepare a compound shown as a formula (III); reacting the compound shown in the formula (III) with a compound shown in the formula (II) to prepare the compound shown in the formula (I). According to the technical scheme, a triazole group is introduced into 1H-1, 2, 4-triazole-1-acetic acid, generation of an isomer 1, 3, 4-triazole byproduct is avoided, the reaction yield is increased, and the method has the advantages of being simple and convenient in process route, few in reaction step, simple in process, low in production cost, environmentally friendly, green and safe; the post-treatment of the product only needs a simple solvent crystallization process, a nitric acid salifying method and a high-temperature distillation method do not need to be adopted, the requirements on equipment are reduced and the cost is reduced under the condition of improving the yield and content of the product, and the method is suitable for industrial production.

Process for synthesizing propiconazole

-

Paragraph 0033-0040, (2021/09/29)

The invention discloses a process method for synthesizing propiconazole. To 2, 4 -dichloro acetophenone serves as a starting raw material, and cyclization, bromination and condensation to prepare propiconazole comprises the following steps: 2, 4 -dichloro acetophenone and 1, 2 - pentanediol in a solvent benzene, cyclization reaction is carried out under the action of a catalyst to obtain a cyclized product. A bromide is obtained by brominating the cyclized product with bromine. The bromide, triazole in the solvent are subjected to a condensation reaction under the action of a base and a phase transfer catalyst to obtain propiconazole. The method is mild in reaction condition, simple and convenient to operate, capable of avoiding the generation of propiconazole isomer, improving the purity of propiconazole, high in reaction yield, reduced by-products and reduced in production cost.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 60207-90-1